Revenue segments as reported by the company.

Clearing and transaction fees

Market data and information services

Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Compensation and benefits  

Technology

Professional fees and outside services

Amortization of purchased intangibles

Depreciation and amortization

Licensing and other fee agreements

Other expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CME Group

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals. It offers futures and options on futures trading across asset classes through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it also operates CME Clearing, a central counterparty clearing provider. The company was founded in 1898 and is headquartered in Chicago, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CME Group achieves record-breaking 2022 performance amidst market challenges

CME Group's 2022 performance was exceptional, marked by record volumes, revenue growth, and successful transitions. The company's focus on innovation, strategic positioning in energy and cryptocurrency markets, and pricing adjustments have driven positive outcomes. Challenges in margins and market uncertainties require careful navigation.

CME Group posts record Q1 earnings, eyes growth in SOFR

CME Group delivered a strong performance in Q1 2023, achieving record revenue and profitability driven by growth in interest rate and options trading.
The company's strategic focus on risk management, shareholder value creation, and market competitiveness positions it well for future growth and revenue generation.
While facing challenges in a competitive market environment, CME Group has opportunities to capitalize on the demand for SOFR products and options trading.
Optimism surrounding the company's future growth potential, coupled with effective expense management and revenue diversification, underpin its resilience and strategic outlook.

CME Group excels in Q2 with record revenue and strategic focus

CME Group's Q2 earnings call showcased strong financial performance, driven by growth across asset classes and a focus on customer-centric strategies. The company's emphasis on innovation, regulatory compliance, and market leadership positions it well for future growth.

CME Group reports strong Q3 earnings, eyes growth amid challenges

CME Group's Q3 2023 earnings call highlighted robust financial performance, operational efficiency, and strategic positioning. Despite facing regulatory challenges and cost management concerns, the company remains confident in its offerings and growth prospects. Opportunities for expansion through innovation and capitalizing on market trends were key discussion points.

CME Group achieves record 2023 results amidst global uncertainties

CME Group's record-breaking performance in 2023 underscores its market leadership and financial strength, with revenue growth, margin expansion, and strong product demand driving positive results.
While facing challenges from global uncertainties and market dynamics, the company's strategic focus on innovation, risk management, and efficiency positions it well to capitalize on opportunities in evolving markets.
By introducing new products, expanding partnerships, and navigating changing market conditions adeptly, CME Group demonstrates resilience and adaptability, paving the way for continued growth and success in the financial industry.
Overall, CME Group's strategic initiatives, financial performance, and market positioning reflect a company poised for sustained success, leveraging opportunities and strengths to overcome challenges and drive future growth.

CME Group achieves record earnings in Q1 2024, eyes growth

CME Group delivered a strong performance in Q1 2024, setting records in revenue and earnings.
The company faces challenges in managing expenses amid growth initiatives and competitive dynamics.
However, CME's strengths in market leadership, network infrastructure, and regulatory alignment position it well for future opportunities.
By capitalizing on data services and revenue growth avenues, CME can continue its upward trajectory in the market.

CME Group achieves record Q3 performance amidst regulatory challenges

CME Group's Q3 performance was exceptional, marked by record volumes and financial metrics. Despite challenges in regulatory compliance and competition, the company is well-positioned for growth through strategic opportunities in interest rate products and retail expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

CME (CME) reported earnings 30 days ago. What's next for the stock?

Why Is CME (CME) Up 0.7% Since Last Earnings Report?

CHICAGO and LONDON , Aug. 16, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, and CF Benchmarks, the leading provider of cryptocurrency benchmark indices, today announced plans to launch two new APAC-specific reference rates for bitcoin and ether on September 11 – the CME CF Bitcoin Reference Rate APAC (BRRAP) and CME CF Ether-Dollar Reference Rate APAC (ETHUSD_AP) – which will provide a once-a-day reference rate for the U.S. dollar price of the two digital assets, published at 4 p.m. Hong Kong/Singapore time.

CME Group and CF Benchmarks to Launch APAC Reference Rates for Bitcoin and Ether on September 11

Paul Houston Appointed to Lead Combined FX Products Group CHICAGO and LONDON , Aug. 16, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced a realignment of its FX futures, options, cash and over-the-counter (OTC) FX businesses into a single unit led by Paul Houston, who has overseen CME Group's futures and options business for seven years.  Under the new structure, Houston will serve as Global Head of FX Products and will be responsible for the company's FX derivatives markets as well as its EBS cash markets business, leveraging a combined team to further improve client service, increase efficiencies and enhance product development across the entire FX marketplace.

CME Group Realigns Foreign Exchange Businesses, Expanding Trading Opportunities and Efficiencies for Clients Across Futures, Cash and OTC Markets

Associated Banc-Corp

BOK Financial

Commerce Bancshares

First Republic Bank

Fulton Financial

Goldman Sachs

Moody's

M&T Bank

Prosperity Bancshares

Moody's recently downgraded 10 small and midsize regional banks citing financial strains that could hurt their profitability. Commerce Bancshares, Old National Bancorp, and M&T Bank were among the banks downgraded.

Moody's Downgrades 10 Banks: Here's What Investors Need to Know

More than $3.1 million in Foundation scholarships awarded since 2019 Students eligible for $20,000 in grants each year for up to three years CHICAGO , Aug. 14, 2023 /PRNewswire/ -- CME Group Foundation today announced that 18 rising Black and Latinx students majoring in finance, technology and related fields at 11 partner colleges and universities in Illinois have each been awarded $20,000 in scholarships to further their education. With this addition, CME Group Foundation is currently providing scholarships to 33 college students for the 2023-24 academic year.

CME Group Foundation Awards 2023 Higher Education Scholarships to Rising Black and Latinx Students

Albemarle

ChampionX

Chart Industries

McDonald's

Microsoft

Micron Technology

NVIDIA

Roku

T. Rowe Price Group

Earlier this month, Finbold released an article about ‘The GPT Portfolio' – a group of investors who are managing a $50,000 portfolio of stocks based entirely on OpenAI's ChatGPT suggestions.

Here's how a ChatGPT-based stock portfolio performed last week

Wall Street is undecided about trying for another rally on Friday, according to early trading in futures. That's in keeping with the struggle it has been of late, with the S&P 500 SPX down six of the last eight sessions amid August's bearish tendencies.

If America debt spiral gets worse, here's the stock that may benefit, says fund manager

Hive Blockchain Technologies Ltd

Block

As the cryptocurrency market is poised to pull out of its doldrums, it's judicious for risk-tolerant investors to closely watch HIVE Blockchain (HIVE), Block (SQ) and CME Group (CME).

3 Crypto Stocks to Keep a Tab on in August

Strongest July ADV in company history for interest rate, agricultural and options products SOFR futures and options continue strong ADV growth CHICAGO , Aug. 2, 2023 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today reported its July 2023 market statistics, reaching an average daily volume (ADV) of 19.9 million contracts during the month, the second-highest July ADV in company history. Market statistics are available in greater detail at https://cmegroupinc.gcs-web.com/monthly-volume.

CME Group Reports Second-Highest July ADV on Record

CME Group's stock is up 18% year-to-date after strong earnings, validating the long-term bull case. The company saw growth in key segments like interest rates and commodities, demonstrating the scalability of its business model. CME's higher rate per contract indicates increased profitability, and its commitment to steady dividend distributions makes it an attractive investment opportunity.

Dividend Investors Take Note - CME Group Is Back

"It's really hard to predict what the Fed is ultimately going to do," CME Group Chairman and CEO Terry Duffy says.

CME Group CEO Terry Duffy: Manage your risk because everyone I've talked to got Fed 'dead wrong'

With a daily gain of 3.94% and an Earnings Per Share (EPS) (EPS) of $7.87, CME Group Inc ( CME , Financial) has caught the attention of many investors. But is the stock fairly valued?

Is CME Group Inc (CME) Fairly Valued? An In-Depth Analysis

CME Group (CME) Q2 results reflect higher revenues on increased trading volume.

CME Group (CME) Q2 Earnings Top on Higher Trading Volume

CME Group Inc. (NASDAQ:CME ) Q2 2023 Earnings Conference Call July 26, 2023 8:30 AM ET Company Participants Adam Minick - Senior Director, IR Terrence Duffy - Chairman & CEO Lynne Fitzpatrick - CFO Tim McCourt - Senior Managing Director and Global Head, Equity & FX Products Derek Sammann - Senior Managing Director and Global Head, Commodities, Options & International Markets Julie Winkler - Chief Commercial Officer Sunil Cutinho - Chief Information Officer Conference Call Participants Benjamin Budish - Barclays Dan Fannon - Jefferies Kyle Voigt - KBW Simon Clinch - Atlantic Equities Alexander Kramm - UBS Brian Bedell - Deutsche Bank Craig Siegenthaler - Bank of America Owen Lau - Oppenheimer Ken Worthington - JPMorgan Michael Cyprys - Morgan Stanley Patrick Mally - Piper Sandler Chris Allen - Citi Andrew Bond - Rosenblat Securities Operator Greetings and welcome to the CME Group Second Quarter 2023 Earnings Conference Call. During this presentation, participants are in a listen-only mode.

CME Group Inc. (CME) Q2 2023 Earnings Call Transcript

The headline numbers for CME (CME) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

CME (CME) Reports Q2 Earnings: What Key Metrics Have to Say

Accenture Plc

Accenture (ACN), CME Group (CME) and HIVE Digital (HIVE) are three Ethereum-exposed stocks that should be tracked as the Bitcoin rival continues to rise in 2023.

3 Crypto Stocks to Watch in the 2023 Ethereum Rally

CME Group (CME) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $1.97 per share a year ago.

CME Group (CME) Q2 Earnings and Revenues Top Estimates

Double-digit growth in revenue and adjusted earnings per share CHICAGO , July 26, 2023 /PRNewswire/ -- CME Group Inc. (NASDAQ: CME) today reported financial results for the second quarter of 2023. The company reported revenue of $1.4 billion and operating income of $839 million for the second quarter of 2023.

CME Group Inc. Reports Second-Quarter 2023 Financial Results

CME Group's (CME) Q2 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.

CME Group (CME) Set to Report Q2 Earnings: What to Expect

Ameren

AstraZeneca

Biogen

CNH Industrial NV

Genuine Parts

Intercontinental Exchange

iShares Trust iShares 1-5 Year Investment Grade Corporate Bond ETF

Itau Unibanco Holding S.A.

Cie Generale des Etablissements Michelin SCA

Mueller Industries

Paramount Global

Siemens AG

Sylvamo Corp

TEGNA

Target

Textron

Barron's Mid-Year Roundtable, Published July 17, listed 40 stocks of note for 2023; 38 of those were unduplicated US publicly-listed companies, of-which YCharts reported 25 as paying dividends. Barron's interviews with their ten financial-industry Roundtable pros tapped human intelligence (HI) to make predictions. Unfortunately, the YCharts screener employed to report current data, dropped seven funds off the list. Nevertheless, the Watchlist tracked by YCharts as of 7/19/23 projected ten top analyst-estimated net gains from ICE, PARA, TXT, AZN, MLI, BIIB, SIEGY, CHNI, TGNA, & topped by SLVM, ranging from 15.53%-31.31%.

4 Ideal Barron's Mid-Year 2023 Dividend Dog Buys

CME Group , the world's largest derivatives exchange, eliminated about 100 positions, or 3% of its workforce, this week while reallocating some positions, a spokesperson said on Friday.

CME Group to lay off 3% of its workforce, reallocate positions

Enhancements to long-standing cross-margining agreement will launch in January 2024, pending regulatory approval Clearing members will be eligible to gain greater margin efficiencies between U.S. Treasury securities and CME Group Interest Rate futures CHICAGO, NEW YORK, LONDON, HONG KONG, SINGAPORE, SYDNEY , July 18, 2023 /PRNewswire/ --  CME Group , the world's leading derivatives marketplace, and The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, today announced enhancements to their existing cross-margining arrangement that will increase capital efficiencies for clearing members that trade and clear both U.S. Treasury securities and CME Group Interest Rate futures. The proposed changes, subject to regulatory approval, are expected to launch in January 2024.

CME Group and DTCC to Increase Cross-Margining Opportunities for the Treasury Markets

Adobe

Paychex

When great stocks go on sale investors must act decisively.

3 Incredible Stocks Trading at Historical Discounts

Agilent Technologies

Autodesk

Amgen

Bank of America

Bank of New York Mellon

Blackrock Inc

Comcast

Compass Minerals

Campbell Soup

Copart

Cheniere Energy Partners

Corteva Inc

Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of the most investable candidates that may be worth your time for further analysis.

U.S. Wide-Moat Stocks On Sale - The July 2023 Heat Map

News for CME Group Stock (CME)